CFDE Data Portal | Search SCGB2A1

	Label	Description
	SCGB2A1 associations Collection (Entity type)	Associations for SCGB2A1_associations
	SCGB2A1 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	GSE172016 paclitaxel 2 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE118490 1 V 0 TRAMETINIB HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	SCGB2A1 Gene (Entity type)	ENSG00000124939 - secretoglobin family 2A member 1
	GSE142210 4 V 7 PANOBINOSTAT HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE193258,GSE193259 2 V 4 OSIMERTINIB HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE172016 2 V 1 PACLITAXEL HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE216540 1 V 6 FULVESTRANT HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE185200 GSE185202 L-13 Ali-BL 0 v 9 human dn Gene Set (Entity type)	A Gene Set from LINCS

SCGB2A1 associations

Associations for SCGB2A1_associations

SCGB2A1 associations.tsv

A file from IDG as part of the Harmonizome project

GSE172016 paclitaxel 2 v 1 human up

A Gene Set from LINCS

GSE118490 1 V 0 TRAMETINIB HUMAN UP

A Gene Set from LINCS

SCGB2A1

ENSG00000124939 - secretoglobin family 2A member 1

GSE142210 4 V 7 PANOBINOSTAT HUMAN UP

A Gene Set from LINCS

GSE193258,GSE193259 2 V 4 OSIMERTINIB HUMAN DN

A Gene Set from LINCS

GSE172016 2 V 1 PACLITAXEL HUMAN UP

A Gene Set from LINCS

GSE216540 1 V 6 FULVESTRANT HUMAN UP

A Gene Set from LINCS

GSE185200 GSE185202 L-13 Ali-BL 0 v 9 human dn

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.